Variability of duration of action of neuromuscular-blocking drugs in elderly patients

Background:  Steroid‐based, non‐depolarizing neuromuscular‐blocking (NMB) drugs (e.g. rocuronium, vecuronium) are characterized by organ‐dependent elimination and significantly longer durations of action in elderly compared to young patients. Cisatracurium is a benzylisoquinolinium NMB drug with a d...

Full description

Saved in:
Bibliographic Details
Published inActa anaesthesiologica Scandinavica Vol. 49; no. 3; pp. 312 - 315
Main Authors Arain, S. R., Kern, S., Ficke, D. J., Ebert, T. J.
Format Journal Article
LanguageEnglish
Published Oxford, UK; Malden, USA Blackwell Publishing Ltd/Inc 01.03.2005
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background:  Steroid‐based, non‐depolarizing neuromuscular‐blocking (NMB) drugs (e.g. rocuronium, vecuronium) are characterized by organ‐dependent elimination and significantly longer durations of action in elderly compared to young patients. Cisatracurium is a benzylisoquinolinium NMB drug with a duration of action not altered by ageing. The objective of the study was to determine if elderly patients had less variability in duration of action with 2 × ED95 of cisatracurium compared to equipotent doses of rocuronium or vecuronium. Methods:  Informed consent was obtained from 66 elderly patients with normal renal and liver function. Preoperative midazolam (1 mg) was given IV. The anaesthestic induction was with 5 mg kg−1 thiopental and 2 µg kg−1 fentanyl. The patients received 0.6 mg kg−1 rocuronium, 0.1 mg kg−1 vecuronium or 0.1 mg kg−1 cisatracurium. Anaesthetic maintenance was with sevoflurane in oxygen/nitrous oxide. Neuromuscular‐blocking duration of action was defined as the return of T1 twitch height to 25% of control. Variability was determined by subtracting the actual duration of action from the mean duration of action for each drug. Results:  The durations of action (range, min) were: cisatracurium, 37–81; vecuronium, 35–137; and rocuronium, 33–119. The median of the variability of duration was significantly less with cisatracurium (7 min) compared to vecuronium (18 min) and rocuronium (18 min) (P < 0.05). Conclusion:  When used with sevoflurane/N2O, there was a two‐fold greater variability of duration of neuromuscular blockade in elderly patients receiving rocuronium or vecuronium compared with cisatracurium.
AbstractList Background:  Steroid‐based, non‐depolarizing neuromuscular‐blocking (NMB) drugs (e.g. rocuronium, vecuronium) are characterized by organ‐dependent elimination and significantly longer durations of action in elderly compared to young patients. Cisatracurium is a benzylisoquinolinium NMB drug with a duration of action not altered by ageing. The objective of the study was to determine if elderly patients had less variability in duration of action with 2 × ED95 of cisatracurium compared to equipotent doses of rocuronium or vecuronium. Methods:  Informed consent was obtained from 66 elderly patients with normal renal and liver function. Preoperative midazolam (1 mg) was given IV. The anaesthestic induction was with 5 mg kg−1 thiopental and 2 µg kg−1 fentanyl. The patients received 0.6 mg kg−1 rocuronium, 0.1 mg kg−1 vecuronium or 0.1 mg kg−1 cisatracurium. Anaesthetic maintenance was with sevoflurane in oxygen/nitrous oxide. Neuromuscular‐blocking duration of action was defined as the return of T1 twitch height to 25% of control. Variability was determined by subtracting the actual duration of action from the mean duration of action for each drug. Results:  The durations of action (range, min) were: cisatracurium, 37–81; vecuronium, 35–137; and rocuronium, 33–119. The median of the variability of duration was significantly less with cisatracurium (7 min) compared to vecuronium (18 min) and rocuronium (18 min) (P < 0.05). Conclusion:  When used with sevoflurane/N2O, there was a two‐fold greater variability of duration of neuromuscular blockade in elderly patients receiving rocuronium or vecuronium compared with cisatracurium.
Steroid-based, non-depolarizing neuromuscular-blocking (NMB) drugs (e.g. rocuronium, vecuronium) are characterized by organ-dependent elimination and significantly longer durations of action in elderly compared to young patients. Cisatracurium is a benzylisoquinolinium NMB drug with a duration of action not altered by ageing. The objective of the study was to determine if elderly patients had less variability in duration of action with 2 x ED95 of cisatracurium compared to equipotent doses of rocuronium or vecuronium. Informed consent was obtained from 66 elderly patients with normal renal and liver function. Preoperative midazolam (1 mg) was given IV. The anaesthestic induction was with 5 mg kg(-1) thiopental and 2 microg kg(-1) fentanyl. The patients received 0.6 mg kg(-1) rocuronium, 0.1 mg kg(-1) vecuronium or 0.1 mg kg(-1) cisatracurium. Anaesthetic maintenance was with sevoflurane in oxygen/nitrous oxide. Neuromuscular-blocking duration of action was defined as the return of T1 twitch height to 25% of control. Variability was determined by subtracting the actual duration of action from the mean duration of action for each drug. The durations of action (range, min) were: cisatracurium, 37-81; vecuronium, 35-137; and rocuronium, 33-119. The median of the variability of duration was significantly less with cisatracurium (7 min) compared to vecuronium (18 min) and rocuronium (18 min) (P < 0.05). When used with sevoflurane/N(2)O, there was a two-fold greater variability of duration of neuromuscular blockade in elderly patients receiving rocuronium or vecuronium compared with cisatracurium.
BACKGROUNDSteroid-based, non-depolarizing neuromuscular-blocking (NMB) drugs (e.g. rocuronium, vecuronium) are characterized by organ-dependent elimination and significantly longer durations of action in elderly compared to young patients. Cisatracurium is a benzylisoquinolinium NMB drug with a duration of action not altered by ageing. The objective of the study was to determine if elderly patients had less variability in duration of action with 2 x ED95 of cisatracurium compared to equipotent doses of rocuronium or vecuronium.METHODSInformed consent was obtained from 66 elderly patients with normal renal and liver function. Preoperative midazolam (1 mg) was given IV. The anaesthestic induction was with 5 mg kg(-1) thiopental and 2 microg kg(-1) fentanyl. The patients received 0.6 mg kg(-1) rocuronium, 0.1 mg kg(-1) vecuronium or 0.1 mg kg(-1) cisatracurium. Anaesthetic maintenance was with sevoflurane in oxygen/nitrous oxide. Neuromuscular-blocking duration of action was defined as the return of T1 twitch height to 25% of control. Variability was determined by subtracting the actual duration of action from the mean duration of action for each drug.RESULTSThe durations of action (range, min) were: cisatracurium, 37-81; vecuronium, 35-137; and rocuronium, 33-119. The median of the variability of duration was significantly less with cisatracurium (7 min) compared to vecuronium (18 min) and rocuronium (18 min) (P < 0.05).CONCLUSIONWhen used with sevoflurane/N(2)O, there was a two-fold greater variability of duration of neuromuscular blockade in elderly patients receiving rocuronium or vecuronium compared with cisatracurium.
Background:  Steroid‐based, non‐depolarizing neuromuscular‐blocking (NMB) drugs (e.g. rocuronium, vecuronium) are characterized by organ‐dependent elimination and significantly longer durations of action in elderly compared to young patients. Cisatracurium is a benzylisoquinolinium NMB drug with a duration of action not altered by ageing. The objective of the study was to determine if elderly patients had less variability in duration of action with 2 × ED95 of cisatracurium compared to equipotent doses of rocuronium or vecuronium. Methods:  Informed consent was obtained from 66 elderly patients with normal renal and liver function. Preoperative midazolam (1 mg) was given IV. The anaesthestic induction was with 5 mg kg −1 thiopental and 2 µg kg −1 fentanyl. The patients received 0.6 mg kg −1 rocuronium, 0.1 mg kg −1 vecuronium or 0.1 mg kg −1 cisatracurium. Anaesthetic maintenance was with sevoflurane in oxygen/nitrous oxide. Neuromuscular‐blocking duration of action was defined as the return of T1 twitch height to 25% of control. Variability was determined by subtracting the actual duration of action from the mean duration of action for each drug. Results:  The durations of action (range, min) were: cisatracurium, 37–81; vecuronium, 35–137; and rocuronium, 33–119. The median of the variability of duration was significantly less with cisatracurium (7 min) compared to vecuronium (18 min) and rocuronium (18 min) ( P <  0.05). Conclusion:  When used with sevoflurane/N 2 O, there was a two‐fold greater variability of duration of neuromuscular blockade in elderly patients receiving rocuronium or vecuronium compared with cisatracurium.
Author Arain, S. R.
Ficke, D. J.
Kern, S.
Ebert, T. J.
Author_xml – sequence: 1
  givenname: S. R.
  surname: Arain
  fullname: Arain, S. R.
  organization: Department of Anaesthesiology, Medical College of Wisconsin and Zablocki VA Medical Center, Milwaukee, WI, and
– sequence: 2
  givenname: S.
  surname: Kern
  fullname: Kern, S.
  organization: University of Utah Medical Center, Salt Lake City, UT
– sequence: 3
  givenname: D. J.
  surname: Ficke
  fullname: Ficke, D. J.
  organization: Department of Anaesthesiology, Medical College of Wisconsin and Zablocki VA Medical Center, Milwaukee, WI, and
– sequence: 4
  givenname: T. J.
  surname: Ebert
  fullname: Ebert, T. J.
  email: tjebert@mcw.edu
  organization: Department of Anaesthesiology, Medical College of Wisconsin and Zablocki VA Medical Center, Milwaukee, WI, and
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16864597$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15752394$$D View this record in MEDLINE/PubMed
BookMark eNqNkE9P2zAYhy3ENArsK6Bc4JbMf-NY4lJ1G7DBOAzG0XIcG7m4TmcnWvvt56wdXOeLX-t9ntf27xgchj4YAAoEK5TXx2WFiBBlzXhdYQhZBWFNaLU5ALPXxiGYQQhRyRDHR-A4pWU-EirEe3CEGGeYCDoDjz9VdKp13g3bordFN0Y1uD5MtdL_qmDG2K_GpEevYtn6Xr-48Fx0cXxOhQuF8Z2Jfluss2vCkE7BO6t8Mh_2-wl4_PL5YXFd3t5f3Szmt6WmhNKSwo4YVTPKSdtarFCHuaACEYt1wzGDWhhGEdUNITj3oIVtFhtLam07g8kJuNjNXcf-12jSIFcuaeO9CqYfk6w5FZQjkcFmB-rYpxSNlevoVipuJYJyilQu5ZScnJKTU6Tyb6Ryk9Wz_R1juzLdm7jPMAPne0AlrbyNKmiX3ri6qSkTPHOXO-6382b73w-Q8_mPXGS93OkuDWbzqqv4kr9JOJNP368kvPt2Bx8WX-Un8gdGHqKu
CODEN AANEAB
CitedBy_id crossref_primary_10_1111_aas_12698
crossref_primary_10_1016_j_vaa_2020_03_002
crossref_primary_10_1097_ACO_0b013e328333ec47
crossref_primary_10_1111_j_1399_6576_2007_01549_x
crossref_primary_10_1007_s00101_008_1455_2
crossref_primary_10_1007_s00540_018_2587_4
crossref_primary_10_1213_ANE_0000000000001476
crossref_primary_10_3389_fphar_2021_831149
crossref_primary_10_1007_s40140_020_00389_3
crossref_primary_10_1016_j_jclinane_2016_07_031
crossref_primary_10_1097_ACO_0000000000000134
crossref_primary_10_1590_S0100_879X2012007500076
crossref_primary_10_1097_ALN_0000000000000865
crossref_primary_10_1007_s40266_016_0413_y
crossref_primary_10_1080_22201173_2008_10872541
crossref_primary_10_1016_j_accpm_2020_01_004
crossref_primary_10_1016_j_rca_2016_08_002
crossref_primary_10_1097_EJA_0b013e328361d342
crossref_primary_10_1186_s12871_020_00982_3
crossref_primary_10_1016_j_atc_2006_05_003
crossref_primary_10_1111_j_1365_2044_2006_04862_x
crossref_primary_10_5124_jkma_2017_60_5_371
crossref_primary_10_1016_j_bjae_2023_10_005
crossref_primary_10_4266_kjccm_2012_27_3_145
crossref_primary_10_1097_ACO_0b013e328331a4eb
crossref_primary_10_1016_j_archger_2016_02_005
crossref_primary_10_1016_j_bja_2021_01_029
crossref_primary_10_21320_1818_474X_2017_1_24_28
crossref_primary_10_1111_aas_13645
crossref_primary_10_1093_bja_aem213
crossref_primary_10_1186_s12871_017_0402_7
crossref_primary_10_1016_j_annfar_2011_07_009
crossref_primary_10_1097_01819236_201701000_00004
crossref_primary_10_1007_s40140_017_0242_5
crossref_primary_10_1007_s40140_020_00386_6
crossref_primary_10_1213_XAA_0000000000000554
crossref_primary_10_1016_S1280_4703_17_86782_7
crossref_primary_10_1016_j_rcae_2016_11_002
crossref_primary_10_1111_j_1399_6576_2011_02605_x
crossref_primary_10_1213_ANE_0000000000006035
crossref_primary_10_1111_j_1399_6576_2009_01977_x
crossref_primary_10_1111_vop_13074
crossref_primary_10_4097_kjae_2016_69_5_453
crossref_primary_10_1186_s12871_022_01881_5
crossref_primary_10_1097_MD_0000000000013940
crossref_primary_10_1111_j_1399_6576_2011_02596_x
crossref_primary_10_5812_aapm_8406
crossref_primary_10_1186_1471_2253_11_10
crossref_primary_10_7759_cureus_19245
crossref_primary_10_1080_10790268_2021_1940794
crossref_primary_10_1007_s40266_022_00969_4
crossref_primary_10_5507_bp_2011_050
crossref_primary_10_1111_aas_12155
Cites_doi 10.1097/00000542-199602000-00007
10.1111/j.1399-6576.1996.tb04482.x
10.1111/j.1399-6576.1997.tb04851.x
10.1097/00000542-199603000-00005
10.1046/j.1365-2044.2001.01921.x
10.1016/S0039-6109(16)46226-2
10.2165/00002512-200320020-00004
10.1097/00000542-199602000-00014
10.1213/00000539-199107000-00008
10.1111/j.1399-6576.1988.tb02692.x
10.1097/00000542-199605000-00010
10.1111/j.1399-6576.1988.tb02686.x
10.1213/00000539-199405000-00025
10.1023/B:JOCM.0000012481.06502.02
10.1097/00000542-199711000-00005
10.1093/bja/76.2.179
10.1034/j.1399-6576.2002.460406.x
10.1093/oxfordjournals.bja.a013445
10.1213/00000539-199312000-00019
ContentType Journal Article
Copyright 2005 INIST-CNRS
Copyright_xml – notice: 2005 INIST-CNRS
DBID BSCLL
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1111/j.1399-6576.2005.00634.x
DatabaseName Istex
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1399-6576
EndPage 315
ExternalDocumentID 10_1111_j_1399_6576_2005_00634_x
15752394
16864597
AAS634
ark_67375_WNG_0MKM0TCJ_D
Genre article
Comparative Study
Clinical Trial
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23M
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AAQQT
AASGY
AAVGM
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABHUG
ABJNI
ABLJU
ABPTK
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXME
ACXQS
ADAWD
ADBBV
ADBTR
ADDAD
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEQTP
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFVGU
AFZJQ
AGJLS
AHBTC
AHEFC
AIACR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUOVR
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HVGLF
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
NF~
O66
O9-
OVD
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V9Y
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
ZA5
ZGI
ZXP
ZZTAW
~IA
~WT
AITYG
HGLYW
OIG
08R
AAPBV
AAUGY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c4344-40d3ea65473bbf2a1d2794913f2c87250c9e5414c8332d270f0b4348f36cfde23
IEDL.DBID DR2
ISSN 0001-5172
IngestDate Fri Aug 16 09:19:10 EDT 2024
Fri Aug 23 02:48:12 EDT 2024
Thu May 23 23:07:36 EDT 2024
Sun Oct 22 16:07:55 EDT 2023
Sat Aug 24 00:58:26 EDT 2024
Wed Jan 17 05:00:53 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Human
cisatracurium
Variability
Anesthesia
rocuronium
recovery
Elderly
Neuromuscular blocking
Age
vecuronium
Duration of action
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4344-40d3ea65473bbf2a1d2794913f2c87250c9e5414c8332d270f0b4348f36cfde23
Notes ark:/67375/WNG-0MKM0TCJ-D
istex:B7F94BB48E34519D81AD8344DA59F46B3EC67EEC
ArticleID:AAS634
This study was performed at the VAMC, Milwaukee. Technical support for the TOF‐WatchSX and the statistical analyses were from Utah. Funding: supported in part by an Educational Grant from Abbott Laboratories, Inc.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-News-3
content type line 23
PMID 15752394
PQID 67494719
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_67494719
crossref_primary_10_1111_j_1399_6576_2005_00634_x
pubmed_primary_15752394
pascalfrancis_primary_16864597
wiley_primary_10_1111_j_1399_6576_2005_00634_x_AAS634
istex_primary_ark_67375_WNG_0MKM0TCJ_D
PublicationCentury 2000
PublicationDate March 2005
PublicationDateYYYYMMDD 2005-03-01
PublicationDate_xml – month: 03
  year: 2005
  text: March 2005
PublicationDecade 2000
PublicationPlace Oxford, UK; Malden, USA
PublicationPlace_xml – name: Oxford, UK; Malden, USA
– name: Oxford
– name: England
PublicationTitle Acta anaesthesiologica Scandinavica
PublicationTitleAlternate Acta Anaesthesiol Scand
PublicationYear 2005
Publisher Blackwell Publishing Ltd/Inc
Blackwell
Publisher_xml – name: Blackwell Publishing Ltd/Inc
– name: Blackwell
References Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P et al. New equipment for neuromuscular transmission monitoring: a comparison of the TOF-Guard with the Myograph 2000. J Clin Monit Comput 1998; 14: 19-27.DOI: 10.1023/B:JOCM.0000012481.06502.02
Andersen B, Madsen JV, Schurizek BA et al. Residual curarisation: a comparative study of atracurium and pancuronium. Acta Anaesthesiol Scand 1988; 32: 79-81.
Pühringer FK, Heier T, Dodgson M et al. Double-blind comparison of the variability in spontaneous recovery of cisatracurium- and vecuronium-induced meuromuscular block in adult and elderly patients. Acta Anaesthesiol Scand 2002; 46: 364-71.DOI: 10.1034/j.1399-6576.2002.460406.x
Berg H, Viby-Morgensen J, Roed J et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41: 1095-103.
Cope TM, Hunter JM. Selecting neuromuscular-blocking drugs for elderly patients. Drugs Aging 2003; 20: 126-40.
Lien C, Matteo RS, Ornstein E et al. Distribution, elimination, and action of vecuronium in the elderly. Anesth Analg 1991; 73: 39-42.
Ornstein E, Lien CA, Matteo RS et al. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical pateints. Anesthesiology 1996; 84: 520-5.DOI: 10.1097/00000542-199603000-00005
Kern SE, Johnson JO, Westenskow DR et al. An effectiveness study of a new piezoelectric sensor for train-of-four measurement. Anesth Analg 1994; 78: 978-82.
Mapleson WW. Effect of age on MAC in humans: a meta-analysis. Br J Anaesth 1996; 76: 179-85.
Hayes AH, Mirakhur RK, Breslin DS et al. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 2001; 56: 312-8.DOI: 10.1046/j.1365-2044.2001.01921.x
Lien CA, Schmith VD, Belmont MR et al. Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1996; 84: 300-8.DOI: 10.1097/00000542-199602000-00007
Eriksson LI, Sundman E, Olsson R et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: Simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 1997; 87: 1035-43.DOI: 10.1097/00000542-199711000-00005
Matteo RS, Ornstein E, Schwartz AE et al. Pharmacokinetics and pharmacodynamics of rocuronium (org 9426) in elderly surgical patients. Anesth Analg 1993; 77: 1193-7.
Eriksson LI. Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants? Acta Anaesthesiol Sca+nd 1996; 40: 520-3.
Baillard C, Gehan G, Reboul-Marty J et al. Residual curarization in the recovery room after vecuronium. Br J Anaesth 2000; 84: 394-5.
Bevan DR, Kahwaji R, Ansermino JM et al. Residual block after mivacurium with or without edrophonium reversal in adults and children. Anesthesiology 1996; 84: 362-7.
Sorooshian SS, Stafford MA, Eastwood NB et al. Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients. Anesthesiology 1996; 84: 1083-91.DOI: 10.1097/00000542-199605000-00010
Viby-Mogensen J, Jensen E, Werner M et al. Measurement of acceleration: a new method of monitoring neuromuscular function. Acta Anaesthesiol Scand 1988; 32: 45-8.
Evers BM, Townsend Jr.CM, Thompson JC. Organ physiology of aging. Surg Clin North Am 1994; 74: 23-39.
1997; 87
1997; 41
1993; 77
2002; 46
1991; 73
1988; 32
1994; 78
2000; 84
1996; 84
1996; 40
2001; 56
1996; 76
1994; 74
2003; 20
1998; 14
e_1_2_5_14_2
e_1_2_5_13_2
e_1_2_5_9_2
e_1_2_5_16_2
e_1_2_5_8_2
e_1_2_5_15_2
e_1_2_5_7_2
e_1_2_5_10_2
e_1_2_5_6_2
e_1_2_5_5_2
e_1_2_5_12_2
e_1_2_5_20_2
e_1_2_5_4_2
e_1_2_5_11_2
e_1_2_5_3_2
e_1_2_5_2_2
e_1_2_5_18_2
e_1_2_5_17_2
e_1_2_5_19_2
References_xml – volume: 84
  start-page: 300
  year: 1996
  end-page: 8
  article-title: Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia
  publication-title: Anesthesiology
– volume: 84
  start-page: 1083
  year: 1996
  end-page: 91
  article-title: Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients
  publication-title: Anesthesiology
– volume: 84
  start-page: 362
  year: 1996
  end-page: 7
  article-title: Residual block after mivacurium with or without edrophonium reversal in adults and children
  publication-title: Anesthesiology
– volume: 20
  start-page: 126
  year: 2003
  end-page: 40
  article-title: Selecting neuromuscular‐blocking drugs for elderly patients
  publication-title: Drugs Aging
– volume: 87
  start-page: 1035
  year: 1997
  end-page: 43
  article-title: Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: Simultaneous videomanometry and mechanomyography of awake human volunteers
  publication-title: Anesthesiology
– volume: 46
  start-page: 364
  year: 2002
  end-page: 71
  article-title: Double‐blind comparison of the variability in spontaneous recovery of cisatracurium‐ and vecuronium‐induced meuromuscular block in adult and elderly patients
  publication-title: Acta Anaesthesiol Scand
– volume: 14
  start-page: 19
  year: 1998
  end-page: 27
  article-title: New equipment for neuromuscular transmission monitoring: a comparison of the TOF‐Guard with the Myograph 2000
  publication-title: J Clin Monit Comput
– volume: 74
  start-page: 23
  year: 1994
  end-page: 39
  article-title: Organ physiology of aging
  publication-title: Surg Clin North Am
– volume: 73
  start-page: 39
  year: 1991
  end-page: 42
  article-title: Distribution, elimination, and action of vecuronium in the elderly
  publication-title: Anesth Analg
– volume: 84
  start-page: 394
  year: 2000
  end-page: 5
  article-title: Residual curarization in the recovery room after vecuronium
  publication-title: Br J Anaesth
– volume: 76
  start-page: 179
  year: 1996
  end-page: 85
  article-title: Effect of age on MAC in humans: a meta‐analysis
  publication-title: Br J Anaesth
– volume: 77
  start-page: 1193
  year: 1993
  end-page: 7
  article-title: Pharmacokinetics and pharmacodynamics of rocuronium (org 9426) in elderly surgical patients
  publication-title: Anesth Analg
– volume: 41
  start-page: 1095
  year: 1997
  end-page: 103
  article-title: Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium
  publication-title: Acta Anaesthesiol Scand
– volume: 40
  start-page: 520
  year: 1996
  end-page: 3
  article-title: Reduced hypoxic chemosensitivity in partially paralysed man. A new property of muscle relaxants?
  publication-title: Acta Anaesthesiol Sca+nd
– volume: 56
  start-page: 312
  year: 2001
  end-page: 8
  article-title: Postoperative residual block after intermediate‐acting neuromuscular blocking drugs
  publication-title: Anaesthesia
– volume: 78
  start-page: 978
  year: 1994
  end-page: 82
  article-title: An effectiveness study of a new piezoelectric sensor for train‐of‐four measurement
  publication-title: Anesth Analg
– volume: 84
  start-page: 520
  year: 1996
  end-page: 5
  article-title: Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical pateints
  publication-title: Anesthesiology
– volume: 32
  start-page: 45
  year: 1988
  end-page: 8
  article-title: Measurement of acceleration: a new method of monitoring neuromuscular function
  publication-title: Acta Anaesthesiol Scand
– volume: 32
  start-page: 79
  year: 1988
  end-page: 81
  article-title: Residual curarisation: a comparative study of atracurium and pancuronium
  publication-title: Acta Anaesthesiol Scand
– ident: e_1_2_5_11_2
  doi: 10.1097/00000542-199602000-00007
– ident: e_1_2_5_8_2
  doi: 10.1111/j.1399-6576.1996.tb04482.x
– ident: e_1_2_5_4_2
  doi: 10.1111/j.1399-6576.1997.tb04851.x
– ident: e_1_2_5_12_2
  doi: 10.1097/00000542-199603000-00005
– ident: e_1_2_5_5_2
  doi: 10.1046/j.1365-2044.2001.01921.x
– ident: e_1_2_5_19_2
  doi: 10.1016/S0039-6109(16)46226-2
– ident: e_1_2_5_20_2
  doi: 10.2165/00002512-200320020-00004
– ident: e_1_2_5_2_2
  doi: 10.1097/00000542-199602000-00014
– ident: e_1_2_5_9_2
  doi: 10.1213/00000539-199107000-00008
– ident: e_1_2_5_3_2
  doi: 10.1111/j.1399-6576.1988.tb02692.x
– ident: e_1_2_5_13_2
  doi: 10.1097/00000542-199605000-00010
– ident: e_1_2_5_15_2
  doi: 10.1111/j.1399-6576.1988.tb02686.x
– ident: e_1_2_5_17_2
  doi: 10.1213/00000539-199405000-00025
– ident: e_1_2_5_16_2
  doi: 10.1023/B:JOCM.0000012481.06502.02
– ident: e_1_2_5_7_2
  doi: 10.1097/00000542-199711000-00005
– ident: e_1_2_5_18_2
  doi: 10.1093/bja/76.2.179
– ident: e_1_2_5_14_2
  doi: 10.1034/j.1399-6576.2002.460406.x
– ident: e_1_2_5_6_2
  doi: 10.1093/oxfordjournals.bja.a013445
– ident: e_1_2_5_10_2
  doi: 10.1213/00000539-199312000-00019
SSID ssj0003499
Score 2.0792737
Snippet Background:  Steroid‐based, non‐depolarizing neuromuscular‐blocking (NMB) drugs (e.g. rocuronium, vecuronium) are characterized by organ‐dependent elimination...
Steroid-based, non-depolarizing neuromuscular-blocking (NMB) drugs (e.g. rocuronium, vecuronium) are characterized by organ-dependent elimination and...
Background:  Steroid‐based, non‐depolarizing neuromuscular‐blocking (NMB) drugs (e.g. rocuronium, vecuronium) are characterized by organ‐dependent elimination...
BACKGROUNDSteroid-based, non-depolarizing neuromuscular-blocking (NMB) drugs (e.g. rocuronium, vecuronium) are characterized by organ-dependent elimination and...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 312
SubjectTerms Age
Aged
Aging - metabolism
Analysis of Variance
Androstanols - pharmacology
Anesthesia
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Atracurium - analogs & derivatives
Atracurium - pharmacology
Biological and medical sciences
cisatracurium
Dose-Response Relationship, Drug
Female
Humans
Male
Medical sciences
Neuromuscular Blocking Agents - pharmacology
Neuromuscular Nondepolarizing Agents - pharmacology
recovery
rocuronium
Time Factors
variability
vecuronium
Vecuronium Bromide - pharmacology
Title Variability of duration of action of neuromuscular-blocking drugs in elderly patients
URI https://api.istex.fr/ark:/67375/WNG-0MKM0TCJ-D/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1399-6576.2005.00634.x
https://www.ncbi.nlm.nih.gov/pubmed/15752394
https://search.proquest.com/docview/67494719
Volume 49
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQuXDhIV4BWnJA3LJK_EpyXPVBVbQ9QEt7s2zHRmhLFm02UsuJn8Bv5Jd0xs52CeoBIS6RpWgcZ8aT-eyMvyHkjXeMFtLpTIqCwQLFi8zkMs80BXRimPS8wsPJs2N5eMqPzsX5kP-EZ2EiP8TNhht6Rvheo4Nr042dHIIrpm7I9daIZHyCeBJ59RAffdgwSTFeD0i4yAQE7XFSz60djSLVXVT6JWZO6g6U52PVi9tg6RjlhjB18IDM1y8Ys1Pmk35lJvb7H9yP_0cDD8n9Ac2m0zj9HpE7rn1Mzj7B-jvSf1-lC582fZxl2I7HKLAViDS_9jEP9tePnwaiKm7bp82y_9ylX9rUYQHxi6t0oH7tnpDTg_2T3cNsqN-QWc44B8s3zOlQ3dgYT3XRUPD-umCe2qoE7GVrh1XIbcUYhXu5zw0IVp5J6xtH2VOy1S5a95yknHqudW7hwjkv69o5U3otrPCFpXmdkGJtK_Ut0nSo35Y3oCaFasKim0IFNanLhLwNRr0R0Ms5prmVQp0dv1P57P0sP9k9UnsJ2RlZffMEWSEXT5mQ1-tpoMA78ZeLbt2i76A7XkP4h_E9i7NjIws4GcvSJ0QEG__1sNV0-hEaL_5R7iW5F9hnQxrdK7K1WvZuG3DVyuwEj7kGO0gUKg
link.rule.ids 315,786,790,1382,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQe4ALFPEKjzYHxC2rJH4kOa5aytJ29wBb2ptlO3aFWrJodyO1nPoT-hv5JczY2S5BPSDEJbIU2UlmPJ7Pk_E3hLx1luaZsCoRPKOwQXE80alIE5UDOtFUOFbi4eTxRIyO2cEpP-3KAeFZmMAPcRtwQ8vw6zUaOAak-1YO3hVzN8QqNiIoGwCg3ATr535_9WnNJUVZ1WHhLOHgtvtpPXeO1PNVmyj2S8ydVAsQnwt1L-4Cpn2c6x3V_iNysfrEkJ9yPmiXemB-_MH--J9ksEUedoA2HoYZ-Jjcs80TcvIFtuCBAfwqnrm4bsNEw3Y4SYEtz6X5rQ2psD-vbzQ4Vozcx_W8PVvEX5vYYg3xi6u4Y39dPCXH---nu6OkK-GQGEYZA-XX1Cpf4Fhrl6uszmEBqDLqclMWAL9MZbEQuSkpzeFe6lINHUtHhXG1zekzstHMGvuCxCx3TKnUwIUxVlSVtbpwihvuMpOnVUSylbLk98DUIX_b4YCYJIoJ625y6cUkLyPyzmv1toOan2OmW8HlyeSDTMeH43S6eyD3IrLdU_v6CaJEOp4iIjureSDBQPGvi2rsrF3AcKwCBADv9zxMj3VfgMpYmT4i3Cv5r19bDoefofHyH_vtkPuj6fhIHn2cHL4iDzwZrc-qe002lvPWvgGYtdTb3nx-AZYoGEw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQKyEuFMQrBdocELesEr-SHFddltKyKwQt7c1yHBuhhWy1u5FaTvwEfiO_hBk72yWoB4S4RJYiO848Mp-d8TeEvHCW0UxanUiRMVigOJFUqUwTTQGdVEw6XuDh5MlUHp7yo3Nx3uU_4VmYwA9xveGGnuG_1-jgF7XrOzkEV0zdkOutEcn4APDkNpeMooWP3m-opBgvOyicJQKidj-r58aReqFqG6V-iamTegnSc6HsxU24tA9zfZwa75DZ-g1Desps0K6qgfn2B_nj_xHBPXK3g7PxMNjffXLLNg_I2UdYgAf-76t47uK6DWaG7XCOAlueSfNrGxJhf37_UUFYxX37uF60n5bx5ya2WEH8y1Xccb8uH5LT8auTg8OkK-CQGM44B9XXzGpf3riqHNVZTcH9y4w5aoocwJcpLZYhNwVjFO6lLq2gY-GYNK62lD0iW828sU9IzKnjWqcGLpzzvCytrXKnhREuMzQtI5KtdaUuAk-H-m19A2JSKCasuimUF5O6jMhLr9TrDnoxwzy3XKiz6WuVTo4n6cnBkRpFZK-n9c0TZIFkPHlE9tdmoMA98Z-Lbuy8XcJwvIT4D_N7HKxj0xeAMtalj4jwOv7raavh8AM0dv-x3z65_W40Vm_fTI-fkjueidan1D0jW6tFa58DxlpVe955fgEuchb7
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Variability+of+duration+of+action+of+neuromuscular-blocking+drugs+in+elderly+patients&rft.jtitle=Acta+anaesthesiologica+Scandinavica&rft.au=Arain%2C+S+R&rft.au=Kern%2C+S&rft.au=Ficke%2C+D+J&rft.au=Ebert%2C+T+J&rft.date=2005-03-01&rft.issn=0001-5172&rft.eissn=1399-6576&rft.volume=49&rft.issue=3&rft.spage=312&rft_id=info:doi/10.1111%2Fj.1399-6576.2005.00634.x&rft_id=info%3Apmid%2F15752394&rft.externalDocID=15752394
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-5172&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-5172&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-5172&client=summon